福维奥拉德鲁森降低在症状前的AMD中的固定稳定性
Jimmy Murari1, Josselin Gautier2,3, Joël Daout1
1Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.
Investigative ophthalmology & visual science
|July 8, 2024
概括
与眼结相关的固定性眼动 (FEM) 的微妙变化可能表明症状前的与年龄有关的黄斑变性 (AMD). 这一发现提供了通过分析眼动信号来检测早期眼病的新方法.
科学领域:
- 眼科医生 眼科 眼科
- 神经科学是一个神经科学.
- 生物医学工程 生物医学工程
背景情况:
- 与年龄相关的黄斑变性 (AMD) 是导致视力丧失的主要原因.
- 早期发现AMD对于有效干预至关重要.
- 骨干是AMD的早期迹象,但其功能影响尚未完全理解.
研究的目的:
- 为了将固定性眼动 (FEM) 的微妙变化与对照组和前症状AMD患者的状眼动联系起来.
- 为了确定解剖功能标记,用于在症状前检测AMD.
- 使用自适应光学视网膜成像用于高分辨率分析.
主要方法:
- 招募了年轻的对照组,年长的对照组和症状前的AMD患者.
- 使用高速自适应光学泛光眼镜 (AO-FIO) 进行视网膜追踪.
- 使用视线依赖成像,高精度测量FEM,并记录了使用视线依赖成像的foveal drusen.
主要成果:
- 固定眼动 (FEM) 被测量得非常精确 (RMS-S2S = 0.0015度).
- 检测到具有较高对比度的小型状 (中位直径=60μm).
- 在患有足干燥的患者中,微干幅度,漂移扩散系数和ISO线面积 (ISOA) 显著更大.
结论:
- 高速,高精度的视网膜追踪在显微水平上特征FEM.
- 骨干干改变固定稳定性,导致补偿性FEM变化.
- 叶和固定稳定性之间的解剖功能联系使得眼睛疾病的症状前检测成为可能.
更多相关视频
相关概念视频
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...